These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33242353)

  • 1. P2Y
    Albayati S; Vemulapalli H; Tsygankov AY; Liverani E
    J Leukoc Biol; 2021 Jul; 110(1):141-153. PubMed ID: 33242353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
    Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-related differences in the response of anti-platelet drug therapies targeting purinergic signaling pathways in sepsis.
    Amoafo EB; Entsie P; Albayati S; Dorsam GP; Kunapuli SP; Kilpatrick LE; Liverani E
    Front Immunol; 2022; 13():1015577. PubMed ID: 36405709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet P2Y
    Amoafo EB; Entsie P; Kang Y; Canobbio I; Liverani E
    Br J Pharmacol; 2024 Feb; 181(4):532-546. PubMed ID: 37525937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2-mediated P2Y
    Zhong H; Waresi M; Zhang W; Han L; Zhao Y; Chen Y; Zhou P; Chang L; Pan G; Wu B; Li J; Zhang S; Shi H; Luo X; Gao W; Qi Z; Ding Z
    Biochem Pharmacol; 2021 Dec; 194():114822. PubMed ID: 34748820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis.
    Rahman M; Gustafsson D; Wang Y; Thorlacius H; Braun OÖ
    Platelets; 2014; 25(4):257-63. PubMed ID: 23855479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets modulate the immune response following trauma by interaction with CD4+ T regulatory cells in a mouse model.
    Bergmann CB; Hefele F; Unger M; Huber-Wagner S; Biberthaler P; van Griensven M; Hanschen M
    Immunol Res; 2016 Apr; 64(2):508-17. PubMed ID: 26471021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y
    Mansour A; Bachelot-Loza C; Nesseler N; Gaussem P; Gouin-Thibault I
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
    Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Signaling Pathway of the ADP Receptor P2Y
    Entsie P; Kang Y; Amoafo EB; Schöneberg T; Liverani E
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism.
    Zhang S; Hu L; Du H; Guo Y; Zhang Y; Niu H; Jin J; Zhang J; Liu J; Zhang X; Kunapuli SP; Ding Z
    Thromb Haemost; 2010 Oct; 104(4):845-57. PubMed ID: 20806121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of P2Y₁₂ receptor and activated platelets during inflammation.
    Liverani E; Kilpatrick LE; Tsygankov AY; Kunapuli SP
    Curr Drug Targets; 2014; 15(7):720-8. PubMed ID: 24845219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet phenotype changes associated with breast cancer and its treatment.
    Holmes CE; Levis JE; Schneider DJ; Bambace NM; Sharma D; Lal I; Wood ME; Muss HB
    Platelets; 2016 Nov; 27(7):703-711. PubMed ID: 27135253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y
    Makkawi M; Howells D; Wright MD; Jackson DE
    Thromb Res; 2018 Jan; 161():12-21. PubMed ID: 29178985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel: interactions with the P2Y12 receptor and clinical relevance.
    Dorsam RT; Murugappan S; Ding Z; Kunapuli SP
    Hematology; 2003 Dec; 8(6):359-65. PubMed ID: 14668029
    [No Abstract]   [Full Text] [Related]  

  • 19. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.